Aspirin Did Not Cut CV Risk in Younger Diabetics : At the same time, the data suggest that low-dose aspirin may reduce total events in older patients.

“We may need to rethink the guidelines,” she suggested, “especially for patients younger than 65.

“To come up with recommendations we also need to assess the risk/benefit ratio,” she continued.

“Diabetes is a high-risk group for cardiovascular events, and Japanese patients are a high-risk group for the use of aspirin because of their risk of hemorrhagic stroke. Conducting this study in Japan, therefore, makes sense. … The safety [in JPAD] was quite reasonable for low-dose aspirin,” she said.